Chronic Fatigue Syndrome Clinical Trial
Official title:
Sex Differences in Exercise-related Post-exertional Malaise in ME/CFS
This pilot study is intended to identify sex differences in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) during recovery from brief but high effort exercise tests. It is expected that women with ME/CFS as compared to males with ME/CFS will show slower recovery from exercise with respect to heart rate and blood pressure, physical functioning, and symptom severity. Also females with ME/CFS as compared to males with ME/CFS will show greater negative impacts on heart rate, blood pressure, physical functioning and symptom severity after the two exercise tests. The findings will have implications for sex differences in the pathophysiology of post-exertional malaise and activity/exercise self-management recommendations, given the expected detrimental effects of the brief intense exercise tests on patients with ME/CFS.
This supplement to the parent study, Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
(ME/CFS): Activity patterns and autonomic function, is intended to enhance the larger
home-based study with a face-to-face laboratory arm. Specifically, the investigators propose
a pilot study to assess biobehavioral sex differences in ME/CFS during recovery after a brief
high exertion exercise task, i.e., a six-minute walk test repeated on two consecutive days.
The investigators expect adverse symptomatic, functional, and autonomic effects following
this repeat exercise test. This "post-exertional malaise (PEM)" and its impact on global
outcomes is a unique feature of ME/CFS that is being studied in the parent observational
study conducted by participants entirely in their homes. In the proposed supplement, PEM and
its impacts will be captured in real time under controlled conditions in the research team's
laboratory. Of particular interest, autonomic effects of PEM on heart function and blood
pressure using non-invasive research grade monitors. The specific aims are as follows:
Specific Aim 1: After two high-effort six minute walk tests conducted on consecutive days,
female subjects with ME/CFS as compared to male ME/CFS subjects will show slower recovery
with respect to cardiovascular autonomic functioning, physical functioning, and symptom
resolution. Specific Aim 2: Female subjects with ME/CFS as compared to males with ME/CFS will
show greater adverse impact on autonomic and physical functioning and symptom severity after
the day 2 exercise test.
To more accurately characterize exercise recovery abnormalities differentiated by sex, the
investigators propose to longitudinally monitor symptoms, activity levels, and autonomic
status during the week before (baseline) as compared to the week after (follow-up) the two
exercise tests. This pilot study will also provide potential cross-validation of the parent
project which hypothesizes specific relationships between autonomic function symptom severity
and activity limitations. A parallel analysis of sex differences will also be carried out on
the data collected in the parent project.
The pilot study will remain within the scope of the original aims of the parent study to
identify biobehavioral factors related to PEM, symptom-worsening activity patterns, and
non-improvement in ME/CFS. This supplement will expand the parent project's home-based data
collection to a controlled setting with direct observation and verification of exercise tests
carried out by participants in the principal investigator's laboratory.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05454683 -
Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT02075489 -
Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans
|
N/A | |
Completed |
NCT01686074 -
Motor Control in Chronic Fatigue Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT01651754 -
Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT00540254 -
Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00071162 -
Genetics of Fibromyalgia
|
N/A | |
Withdrawn |
NCT04870476 -
Feasibility and Acceptability of the Internet-delivered Treatment "One Step at the Time" for Bodily Distress Syndrome
|
N/A | |
Completed |
NCT05730660 -
Quercetin Phytosome® Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT04542161 -
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Phase 2 | |
Recruiting |
NCT03807973 -
Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.
|
Phase 1 | |
Recruiting |
NCT05719493 -
Effectiveness and Health Benefits of a Nutritional, Chronobiological and Physical Exercise Intervention in Fibromyalgia and Chronic Fatigue Syndrome (SYNCHRONIZE +)
|
N/A | |
Recruiting |
NCT05967052 -
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
|
Phase 2 | |
Terminated |
NCT01730495 -
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01650636 -
Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process
|
N/A | |
Completed |
NCT01156909 -
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01046370 -
A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia
|
N/A | |
Completed |
NCT00100412 -
Hyporeactivity and Gulf War Illness
|
N/A | |
Recruiting |
NCT06128967 -
A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
|
Phase 3 | |
Completed |
NCT02669212 -
Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
|
N/A | |
Not yet recruiting |
NCT06011135 -
Exploring Worry in CFS/ME
|